These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34351481)

  • 21. Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors.
    Lim CM; Clump DA; Heron DE; Ferris RL
    Oral Oncol; 2013 May; 49(5):401-6. PubMed ID: 23332685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
    Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients.
    Khalladi N; Dejean C; Bosset M; Pointreau Y; Kinj R; Racadot S; Castelli J; Huguet F; Renard S; Guihard S; Tao Y; Rouvier JM; Johnson A; Bourhis J; Xu Shan S; Thariat J
    Cancer Radiother; 2021 Dec; 25(8):755-762. PubMed ID: 34565664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis.
    Onal C; Gultekin M; Oymak E; Guler OC; Yilmaz MT; Yuce Sari S; Akkus Yildirim B; Yildiz F
    Int J Gynecol Cancer; 2020 Jun; 30(6):865-872. PubMed ID: 32273293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic body radiotherapy for oligometastatic disease.
    Hanna GG; Landau D
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Ling DC; Vargo JA; Heron DE
    Cancer J; 2016; 22(4):302-6. PubMed ID: 27441751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal oligometastasis cured with stereotactic ablative radiotherapy.
    Malone J; Pantarotto JR; Tiberi D; Malone S
    Radiol Case Rep; 2020 Nov; 15(11):2266-2270. PubMed ID: 32983297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.
    Gogineni E; Rana Z; Vempati P; Karten J; Sharma A; Taylor P; Pereira L; Frank D; Paul D; Seetharamu N; Ghaly M
    Head Neck; 2020 Oct; 42(10):2880-2886. PubMed ID: 32691496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CyberKnife radiotherapy for head and neck cancer].
    Fukuda I; Kumazaki Y; Funakoshi K; Sutani S; Ootani Y; Tukamoto N; Sekine H; Dokiya T
    Brain Nerve; 2011 Mar; 63(3):209-15. PubMed ID: 21386121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A national cancer database analysis on stereotactic body radiation therapy of head and neck cancers.
    Park JJ; Qureshi MM; Lam CM; Faden DL; Truong MT
    Am J Otolaryngol; 2021; 42(3):102913. PubMed ID: 33460976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.
    Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J
    Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy.
    Dohopolski M; Iyengar P
    Ann Palliat Med; 2021 May; 10(5):5944-5953. PubMed ID: 33691460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intensity-modulated radiation therapy and stereotactic body radiation therapy for head and neck tumors: evidence-based medicine].
    Lapierre A; Martin F; Lapeyre M
    Cancer Radiother; 2014 Oct; 18(5-6):468-72. PubMed ID: 25155467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic Radiotherapy for Oligometastasis.
    Otake S; Goto T
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oligometastatic setting in HNSCC: A critical review by the Rete Oncologica Piemonte e Valle d'Aosta multidisciplinary team.
    Denaro N; Succo G; Ostellino O; Airoldi M; Merlano MC; Badellino S; Solinas C; Garrone O; Iorio GC
    Crit Rev Oncol Hematol; 2023 May; 185():103968. PubMed ID: 36965646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter to the editor of radiotherapy and oncology regarding of the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
    Pergolizzi S; Ferini G; Parisi S
    Radiother Oncol; 2022 May; 170():247. PubMed ID: 35278593
    [No Abstract]   [Full Text] [Related]  

  • 38. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers.
    Karam I; Yao M; Heron DE; Poon I; Koyfman SA; Yom SS; Siddiqui F; Lartigau E; Cengiz M; Yamazaki H; Hara W; Phan J; Vargo JA; Lee V; Foote RL; Harter KW; Lee NY; Sahgal A; Lo SS
    Future Oncol; 2017 Mar; 13(7):603-613. PubMed ID: 27842456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.